Journals / Türk Oftalmoloji Dergisi / 2010 / Cilt: 40 - Sayı: 3

25-Gauge transconjunctival suturuless vitrectomy for tdiopathic macular hole

İdiyopatik maküla deliğinde 25-Gauge transkonjonktival sütürsüz vitrektomi

Pages
135–139
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies with a large number of patients and long follow-up are required.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE: To evaluate the effectiveness and safety of 25-Gauge (G) transconjunctival suturuless vitrectomy (TSV) in the treatment of idiopathic macular hole.
📊
Key Findings & Data:METHODS: In this retrospective study, 13 eyes of 13 consecutive patients who underwent 25-G TSV for idiopathic macular hole were evaluated between April 2004 and December 2006 at our instutition.
💡
Conclusion & Impact:Further studies with a large number of patients and long follow-up are required.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

PURPOSE: To evaluate the effectiveness and safety of 25-Gauge (G) transconjunctival suturuless vitrectomy (TSV) in the treatment of idiopathic macular hole. METHODS: In this retrospective study, 13 eyes of 13 consecutive patients who underwent 25-G TSV for idiopathic macular hole were evaluated between April 2004 and December 2006 at our instutition. Main outcome measures were anatomical and functional outcomes, and intraoperative and postoperative complications. Paired samples t-test were used for statistical analysis. RESULTS: Mean follow-up time was 6.7 ± 6.3 (3-26 months) months. Macular hole was closed with a single operation in 12 eyes (92,3%). The patient whose macular hole remained open refused another surgery. Mean logMAR visual acuity was 1.2 ± 0.12 preoperatively and 0.82 ± 0.58 postoperatively (p=0.007, Paired t-test). Visual acuity improved in all eyes except for the patient whose macular hole remained open. Postoperative visual acuity improved 2 or more lines in 4 (30.7 %) eyes and was better than 0.5 in 2 (15.4%) eyes. No severe complication was observed intraoperatively. No sutures were required to close the scleral or conjunctival openings, and no eyes required conversion of surgery to 20-G pars plana vitrectomy. Postoperative complications were transient increase of intraocular pressure in 1 eye (7%) and cataract progression in 3 of 9 phakic eyes (33.3%). CONCLUSIONS: 25-gauge TSV system appears to be an effective and safe procedure in the treatment of idiopathic macular hole. Further studies with a large number of patients and long follow-up are required.

Özet

Amaç: İdiyopatik maküla deliği tedavisinde 25-Gauge (G) transkonjonktival sütürsüz vitrektominin (TSV) etkinliğini ve güvenirliğini araştırmak. Yöntem: Bu retrospektif çalışmada, idiyopatik maküla deliği nedeniyle Nisan 2004 ve Aralık 2006 yılları arasında kliniğimizde 25-G TSV uygulanan ardışık 13 hastanın 13 gözü incelendi. Çalışmada incelenen ana parametreler anatomik ve fonksiyonel başarı ile intraoperatif ve postoperatif komplikasyonlardı. Ameliyat öncesi ve sonrası veriler paired samples t-test yardımı ile istatistiksel olarak karşılaştırıldı. Bulgular: Ortalama takip süresi 6.7 ± 6.3 ay (3-26 ay) idi. Maküla deliği 12 (%92.3) gözde tek operasyonla kapatıldı. Maküla deliği açık kalan hasta tekrar ameliyat olmayı istemedi. Ortalama logMAR görme keskinliği preoperatif 1.2 ± 0.12 iken, postoperatif 0.82 ± 0.58 idi (p=0.007, Paired t-test). Maküla deliği kapanmayan olgu dışındaki tüm olgularda görme keskinliğinde artış saptandı. Görme keskinliği 4 (%30.7) gözde en az 2 sıra artarken, 2 (%15.4) gözde 0.5’in üzerindeydi. Hiçbir gözde ciddi intraoperatif komplikasyon gözlenmedi, 20-G vitrektomiye geçilmedi, konjonktivaya veya skleraya sütür atılmadı. Postoperatif komplikasyon olarak, 1 (%7) gözde geçici göz içi basıncı artışı ve fakik 9 gözün 3’ ünde (%33.3) katarakt oluşumu gözlendi. Tartışma: İdiyopatik maküla deliği tedavisinde 25-G TSV’nin etkin ve güvenilir olduğu gözlendi. Daha çok sayıda hasta içeren ve daha uzun takip süreli çalışmalara gereksinim vardır.

🔖

Cite This Article

DİNÇYILDIZ, A., NOHUTCU, A. F., ÇELİK, G., YANYALI, A. (2022). 25-Gauge transconjunctival suturuless vitrectomy for tdiopathic macular hole. Türk Oftalmoloji Dergisi, Cilt: 40 - Sayı: 3, 135–139. https://ajindex.com/articles/638409

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy: a pars plana approach Trans Am Acad Ophthalmol. Otolaryngol. 1971;75:813-20
  2. O'Malley C, Heintz RM Sr. Vitrectomy with an alternative instrument system. Ann Ophthalmol. 1975;7:585-8,591-4
  3. Chen JC. Sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol. 1996;114:1273-5
  4. Fujii GY, De Juan E Jr, Humayun MS, Pieramici DJ, Chang TS, Awh C, et al. A new 25 Gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002;109:1807-12
  5. Eckardt C. Transconjunctival suturless 23-gauge vitrectomy. Retina. 2005;25:208-11
  6. Fujii GY, De Juan E Jr, Humayun MS, Chang TS, Pieramici DJ, Barnes A, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002;109:1814-20
  7. Yanyali A, Celik E, Horozoglu F, Oner S, Nohutcu AF. 25-Gauge transconjunctival sutureless pars plana vitrectomy. Eur J Ophthalmol. 2006;16:141-7
  8. Shimada H, Nakashizuka H, Mori R, Mizutani Y. Expanded indications for 25-Gauge transconjunctival vitrectomy. Jpn J Ophthalmol. 2005;49:397-401
  9. Yanyal› A, Çelik E, Nohutçu AF, Horozo¤lu F. Transkonjoktival sütürsüz pars plana vitrektomi. Türk oftalmoloji gazetesi. 2005;35,431-6
  10. Rizzo S, Genovesi-Ebert F, Murri S, Belting C, Vento A, Cresti F, et al. 25 Gauge, sutureless vitrectomy andstandard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol. 2006;19:472-9
  11. Wimpissinger B, Kellner L, Brannath W, Krepler K, Stolba U, Mihalics C, et al. 23-gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol.2008;92:1483-7
  12. Yanyali A, Celik E, Horozoglu F, Nohutcu AF. Corneal topographic changes after transconjunctival (25 Gauge) sutureless vitrectomy. Am J Ophthalmol. 2005;140:939-41
  13. Fine HF, Iranmanesh R, Iturralde D, Spaide RF. Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease. Ophthalmology. 2007;114:1197-200
  14. Romero P, Salvat M, Almena M, Baget M, Méndez I. Experience with 25 -gauge transconjunctival vitrectomy compared to a 20-gauge system. Analysis of 132 cases. J Fr Ophtalmol. 2006;29:1025-32
  15. Rizzo S, Belting C, Cresti F, Genovesi-Ebert F. Sutureless 25-gauge vitrectomy for idiopathic macular hole repair. Graefes Arch Clin Exp Ophthalm